#repatha

Amgen’s PCSK9 inhibitor Repatha (evolocumab) was safe and effective at lowering harmful LDL cholesterol among people with HIV in a recent randomized, double-blind clinical trial, Healio reports.

Findings from the BEIJERINCK trial were presented at the virtual American College of Cardiology Scientific Session and published in the Journal of the American College of Cardiology.

Farmasetika.com –Penyakit kardiovaskular adalah penyebab utama kematian dan kecacatan secara global. Salah satu faktor risiko utama penyakit tersebut adalah kondisi yang ditandai dengan tingginya kadar kolesterol dalam darah (hiperkolesterolemia) yang berkaitan dengan penyakit jantung koroner, infark miokard, dan stroke.

Hiperkolesterolemia dan terapinya

Hiperkolesterolemia dapat terjadi…

Amgen’s Repatha Is Too Bloody Pricey for the U.K.

Commercializing Amgen‘s recently approved cholestserol fighter Repatha across the EU hit a road block this week when cost crunchers in the U.K. determined that the drug didn’t deliver the right balance of efficacy and price.

Not good enough Unlike the U.S., where Medicare is unable to negotiate prices directly with drugmakers, drugs have to pass cost hurdles in the U.K. that demonstrate an…

Repatha/evolocumab side effects, cost, dosage, mechanism to lower LDL

Repatha/ evolocumab side effects, Repatha/ evolocumab cost, Repatha/ evolocumab dosage for adults and kids, Repatha/ evolocumab mechanism to reduce LDL or bad cholesterol, Repatha/ evolocumab FDA approval, Repatha/ evolocumab full prescribing information.

Repatha was first approved by FDA on August 27th, 2015. It contains active ingredient evolocumab which belongs monoclonal antibodies.Inactive…

FDA approves Repatha to treat certain patients with high cholesterol

FDA approves Repatha to treat certain patients with high cholesterol 08/27/2015 05:10 PM EDT The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options. August 27, 2015 Release The U.S. Food and Drug Administration today approved Repatha…